Hualan Vaccine: Henan Huaying plans to reduce its holdings by no more than 2%

[Hualan Vaccine: Henan Huaying plans to reduce its holdings by no more than 2%]-Hualan Vaccine announced that shareholder Henan Huaying intends to reduce its holdings of no more than 8.0002 million shares in the company by centralized bidding, accounting for no more than 2% of the company's total share capital.